尤瑞克林联合血栓通对急性缺血性脑梗死患者的临床效果及患者神经功能缺损评分变化与日常生活能力分析
Clinical effect of Ureklin combined with Xueshuantong on patients with the clinical effect of Urekrin combined with Xueshuantong on acute ischemic stroke andchanges of neurological deficit score and ability of daily living were analyzed
ES评分 0
| DOI |
| 刊名 |
Journal of International Psychiatry
|
| 年，卷(期) |
2019, 46(6) |
| 作者 |
|
| 作者单位 |
贺州市人民医院 ;
|
| 摘要 |
【摘要】目的：探讨尤瑞克林联合血栓通对急性缺血性脑梗死（Acute Ischemic Stroke, AIS）患者的临床效果及患者神经功能缺损评分变化与日常生活能力的影响。方法：按随机抽样法选取2017年6月～2019年1月于我院就诊的114例CIS患者为研究对象，按随机数字表法将其分为观察组和对照组，各57例。两组入组前均给予基础性治疗，对照组常规治疗基础上以尤瑞克林进行治疗，而观察组则在对照组的基础上联合使用血栓通，对比两组疗效以及患者治疗前后的神经功能缺损和日常生活能力的变化情况。结果：两组治疗前NIHSS评分对比无显著差异（P＞0.05）；观察组治疗1疗程后以及治疗完毕NIHSS评分低于对照组（P＜0.05）；观察组治疗总有效率高于对照组（P＜0.05）；观察组各项SF-36评分高于对照组（P＜0.05）。结论：在CIS患者中采用尤瑞克林联合血栓通治疗可以提高临床治疗效果，改善患者神经功能缺损以及恢复患者日常生活能力，值得应用。
|
| Abstract |
【Abstract】Objective: To investigate the clinical effects of Ureklin combined with Xueshuantong on patients with acute ischemic cerebral infarction (AIS) and the changes of neurological deficit scores and daily living ability.Methods: A total of 114 CIS patients who were admitted to our hospital from June 2017 to January 2019 were randomly selected according to the random sampling method. They were divided into observation group and control group according to the random number table method, 57 cases each. The two groups were given basic treatment before enrollment, and the control group was treated with uricillin on the basis of routine treatment, while the observation group was combined with thrombus on the basis of the control group. The efficacy of the two groups and the nerves before and after treatment were compared. Changes in functional impairment and daily living ability.Results: There was no significant difference in NIHSS score between the two groups before treatment (P > 0.05); the NIHSS score of the observation group was lower than that of the control group after one course of treatment and after finishing treatment (P < 0.05); the total effective rate of the observation group was higher than the control group (P < 0.05); the SF-36 score of the observation group was higher than the control group (P < 0.05). Conclusion: The treatment of Urekrin combined with Xueshuantong in CIS patients can improve the clinical therapeutic effect, improve the neurological deficit and restore the daily living ability of patients, which is worthy of application.
|
| 关键词 |
【关键词】尤瑞克林；血栓通；急性缺血性脑梗死；神经功能缺损；日常生活能力
|
| KeyWord |
[Key words] Ureklin; Xueshuantong; Acute ischemic cerebral infarction; Neurological impairment; Activity of daily living
|
| 基金项目 |
|
| 页码 |
1063-1066 |
黄德波*.
尤瑞克林联合血栓通对急性缺血性脑梗死患者的临床效果及患者神经功能缺损评分变化与日常生活能力分析 [J].
国际精神病学杂志.
2019; 46; (6).
1063 - 1066.